Busch, Annette: Minderung der allogenen Immunogenität künstlicher Gewebe am Modell Epithelien durch Suppression der MHC-I-Oberflächenexpression



1 Bjorkman PJ, Parham P (1990) "Structure, function, and diversity of class I major histocompatibility complex molecules. " Annu. Rev. Biochem. 59 253-288

2 Uebel S, Tampé R (1999) "Specificity of the proteasome and the TAP transporter. " Curr. Opin. Immunol. 11(2) 203-208

3 Townsend A, Ohlén C, Bastin J, Ljunggren HG, Foster L, Kärre K (1989) "Association of class I major histocompatibility heavy and light chains induced by viral peptides [see comments]. " Nature 340(6233) 443-448

4 Müllbacher A (1997) "Hypothesis MHC class I, rather than just a flagpole for CD8+ T cells is also a protease in its own right. " Immunol. Cell Biol. 75(3) 310-317

5 Falk K, Rötzschke O, Rammensee HG (1990) "Cellular peptide composition governed by major histocompatibility complex class I molecules [see comments]. " Nature 348(6298) 248-251

6 Hughes EA, Ortmann B, Surman M, Cresswell P (1996) "The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum. " J. Exp. Med. 183(4) 1569-1578

7 Elliott T, Willis A, Cerundolo V, Townsend A (1995) "Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. " J. Exp. Med. 181(4) 1481-1491

8 Snyder HL, Yewdell JW, Bennink JR (1994) "Trimming of antigenic peptides in an early secretory compartment. " J. Exp. Med. 180(6) 2389-2394

9 Roelse J, Grommé M, Momburg F, Hämmerling G, Neefjes J (1994) "Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. " J. Exp. Med. 180(5) 1591-1597

10 Cresswell P, Arunachalam B, Bangia N, Dick T, Diedrich G, et al (1999) "Thiol oxidation and reduction in MHC-restricted antigen processing and presentation. " Immunol. Res. 19(2-3) 191-200

11 Oliver JD, Roderick HL, Llewellyn DH, High S (1999) "ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin. " Mol. Biol. Cell 10(8) 2573-2582

12 Van der Wal FJ, Oliver JD, High S (1998) "The transient association of ERp57 with N-glycosylated proteins is regulated by glucose trimming. " Eur. J. Biochem. 256(1) 51-59

13 Morrice NA, Powis SJ (1998) "A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. " Curr. Biol. 8(12) 713-716

14 Hughes EA, Cresswell P (1998) "The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. " Curr. Biol. 8(12) 709-712

15 Bergeron JJ, Brenner MB, Thomas DY, Williams DB (1994) "Calnexin a membrane-bound chaperone of the endoplasmic reticulum. " Trends Biochem. Sci. 19(3) 124-128

16 Hammond C, Helenius A (1995) "Quality control in the secretory pathway. " Curr. Opin. Cell Biol. 7(4) 523-529

17 Williams DB, Watts TH (1995) "Molecular chaperones in antigen presentation. " Curr. Opin. Immunol. 7(1) 77-84

18 Scott JE, Dawson JR (1995) "MHC class I expression and transport in a calnexin-deficient cell line. " J. Immunol. 155(1) 143-148

19 Balow JP, Weissman JD, Kearse KP (1995) "Unique expression of major histocompatibility complex class I proteins in the absence of glucose trimming and calnexin association. " J. Biol. Chem. 270(48) 29025-29029

20 David V, Hochstenbach F, Rajagopalan S, Brenner MB (1993) "Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin). " J. Biol. Chem. 268(13) 9585-9592

21 Sönnichsen B, Füllekrug J, Nguyen Van P, Diekmann W, Robinson DG, Mieskes G (1994) "Retention and retrieval both mechanisms cooperate to maintain calreticulin in the endoplasmic reticulum. " J. Cell Sci. 107(Pt 10) 2705-2717

22 Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P (1996) "Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. " Immunity 5(2) 103-114

23 Heemels MT, Ploegh H (1995) "Generation, translocation, and presentation of MHC class I-restricted peptides. " Annu. Rev. Biochem. 64 463-491

24 DeMars R, Rudersdorf R, Chang C, Petersen J, Strandtmann J, et al (1985) "Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens. " Proc. Natl. Acad. Sci. U. S. A. 82(23) 8183-8187

25 Neefjes JJ, Momburg F, Hämmerling GJ (1993) "Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter [published erratum appears in Science 1994 Apr 1;264(5155) 16]. " Science 261(5122) 769-771

26 Koopmann JO, Post M, Neefjes JJ, Hämmerling GJ, Momburg F (1996) "Translocation of long peptides by transporters associated with antigen processing (TAP). " Eur. J. Immunol. 26(8) 1720-1728

27 Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, et al (1997) "A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. " Science 277(5330) 1306-1309

28 Li S, Sjögren HO, Hellman U, Pettersson RF, Wang P (1997) "Cloning and functional characterization of a subunit of the transporter associated with antigen processing. " Proc. Natl. Acad. Sci. U. S. A. 94(16) 8708-8713

29 Schoenhals GJ, Krishna RM, Grandea AG 3rd, Spies T, Peterson PA, et al (1999) "Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells. " Embo J. 18(3) 743-753

30 Denzin LK, Cresswell P (1995) "HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. " Cell 82(1) 155-165

31 Weber DA, Evavold BD, Jensen PE (1996) "Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM [see comments]. " Science 274(5287) 618-620

32 Peh CA, Laham N, Burrows SR, Zhu Y, McCluskey J (2000) "Distinct functions of tapasin revealed by polymorphism in MHC class I peptide loading. " J. Immunol. 164(1) 292-299

33 Peh CA, Burrows SR, Barnden M, Khanna R, Cresswell P, et al (1998) "HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. " Immunity 8(5) 531-542

34 Suh WK, Derby MA, Cohen-Doyle MF, Schoenhals GJ, Früh K, et al (1999) "Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain. " J. Immunol. 162(3) 1530-1540

35 Lewis JW, Sewell A, Price D, Elliott T (1998) "HLA-A*0201 presents TAP-dependent peptide epitopes to cytotoxic T lymphocytes in the absence of tapasin. " Eur. J. Immunol. 28(10) 3214-3220

36 Deng Y, Gibbs J, Bacík I, Porgador A, Copeman J, et al (1998) "Assembly of MHC class I molecules with biosynthesized endoplasmic reticulum-targeted peptides is inefficient in insect cells and can be enhanced by protease inhibitors. " J. Immunol. 161(4) 1677-1685

37 Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, et al (1997) "Nomenclature for factors of the HLA System, 1996. " Hum. Immunol. 53(1) 98-128

38 Raulet DH (1994) "MHC class I-deficient mice. " Adv. Immunol. 55 381-421

39 Kleijmeer MJ, Kelly A, Geuze HJ, Slot JW, Townsend A, Trowsdale J (1992) "Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. " Nature 357(6376) 342-344

40 Bix M, Raulet D (1992) "Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells. " J. Exp. Med. 176(3) 829-834

41 Freland S, Chambers BJ, Andersson M, Van Kaer L, Ljunggren HG (1998) "Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice. " J. Immunol. 160(2) 572-579

42 Lee RS, Grusby MJ, Laufer TM, Colvin R, Glimcher LH, Auchincloss H Jr (1997) "CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of major histocompatibility complex-deficient skin grafts. " Transplantation 63(8) 1123-1133

43 Ljunggren HG, Van Kaer L, Sabatine MS, Auchincloss H Jr, Tonegawa S, Ploegh HL (1995) "MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice. " Int. Immunol. 7(6) 975-984

44 Wei ML, Cresswell P (1992) "HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides [see comments]. " Nature 356(6368) 443-446

45 Markmann JF, Bassiri H, Desai NM, Odorico JS, Kim JI, et al (1992) "Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. " Transplantation 54(6) 1085-1089

46 Qian S, Fu F, Li Y, Lu L, Rao AS, et al (1996) "Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. " Immunology 88(1) 124-129

47 Cagiannos C, Zhong R, Zang Z, Jiang J, Garcia BM, et al (1998) "Effect of major histocompatibility complex expression on murine intestinal graft survival. " Transplantation 66(10) 1369-1374

48 Coffman T, Geier S, Ibrahim S, Griffiths R, Spurney R, et al (1993) "Improved renal function in mouse kidney allografts lacking MHC class I antigens. " J. Immunol. 151(1) 425-435

49 Zijlstra M, Auchincloss H Jr, Loring JM, Chase CM, Russell PS, Jaenisch R (1992) "Skin graft rejection by beta 2-microglobulin-deficient mice. " J. Exp. Med. 175(4) 885-893

50 Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH (1993) "The role of indirect recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. " Proc. Natl. Acad. Sci. U. S. A. 90(8) 3373-3377

51 Biocca S, Neuberger MS, Cattaneo A (1990) "Expression and targeting of intracellular antibodies in mammalian cells. " Embo J. 9(1) 101-108

52 Werge TM, Biocca S, Cattaneo A (1990) "Intracellular immunization. Cloning and intracellular expression of a monoclonal antibody to the p21ras protein. " FEBS. Lett. 274(1-2) 193-198

53 Chen SY, Bagley J, Marasco WA (1994) "Intracellular antibodies as a new class of therapeutic molecules for gene therapy. " Hum. Gene Ther. 5(5) 595-601

54 Marasco WA, Haseltine WA, Chen SY (1993) "Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody [see comments]. " Proc. Natl. Acad. Sci. U. S. A. 90(16) 7889-7893

55 Whitlow M, Filpula D (1991) "Single-chain Fv proteins and their fusion proteins. " Methods Enzymol. 2(2) 97-105

56 Reiter Y, Brinkmann U, Lee B, Pastan I (1996) "Engineering antibody Fv fragments for cancer detection and therapy disulfide-stabilized Fv fragments. " Nat. Biotechnol. 14(10) 1239-1245

57 Winter G, Milstein C (1991) "Man-made antibodies. " Nature 349(6307) 293-299

58 Greenman J, Jones E, Wright MD, Barclay AN (1996) "The use of intracellular single-chain antibody fragments to inhibit specifically the expression of cell surface molecules. " J. Immunol. Methods 194(2) 169-180

59 Richardson JH, Sodroski JG, Waldmann TA, Marasco WA (1995) "Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor. " Proc. Natl. Acad. Sci. U. S. A. 92(8) 3137-3141

60 Richardson JH, Waldmann TA, Sodroski JG, Marasco WA (1997) "Inducible knockout of the interleukin-2 receptor alpha chain expression of the high-affinity IL-2 receptor is not required for the in vitro growth of HTLV-I-transformed cell lines. " Virology 237(2) 209-216

61 Jannot CB, Beerli RR, Mason S, Gullick WJ, Hynes NE (1996) "Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells. " Oncogene 13(2) 275-282

62 Yuan Q, Strauch KL, Lobb RR, Hemler ME (1996) "Intracellular single-chain antibody inhibits integrin VLA-4 maturation and function. " Biochem. J. 318(Pt 2) 591-596

63 Hynes NE (1993) "Amplification and overexpression of the erbB-2 gene in human tumors its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. " Semin. Cancer Biol. 4(1) 19-26

64 Beerli RR, Wels W, Hynes NE (1994) "Intracellular expression of single chain antibodies reverts ErbB-2 transformation. " J. Biol. Chem. 269(39) 23931-23936

65 Deshane J, Loechel F, Conry RM, Siegal GP, King CR, Curiel DT (1994) "Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines. " Gene Ther. 1(5) 332-337

66 Grim J, Deshane J, Feng M, Lieber A, Kay M, Curiel DT (1996) "erbB-2 knockout employing an intracellular single-chain antibody (sFv) accomplishes specific toxicity in erbB-2-expressing lung cancer cells. " Am. J. Respir. Cell Mol. Biol. 15(3) 348-354

67 Wright M, Grim J, Deshane J, Kim M, Strong TV, et al (1997) "An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2. " Gene Ther. 4(4) 317-322

68 Deshane J, Grim J, Loechel S, Siegal GP, Alvarez RD, Curiel DT (1996) "Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis. " Cancer Gene Ther. 3(2) 89-98

69 Deshane J, Cabrera G, Grim JE, Siegal GP, Pike J, et al (1995) "Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody [see comments]. " Gynecol. Oncol. 59(1) 8-14

70 Deshane J, Siegal GP, Alvarez RD, Wang MH, Feng M, et al (1995) "Targeted tumor killing via an intracellular antibody against erbB-2. " J. Clin. Invest. 96(6) 2980-2989

71 Deshane J, Siegal GP, Wang M, Wright M, Bucy RP, et al (1997) "Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy. " Gynecol. Oncol. 64(3) 378-385

72 Biocca S, Pierandrei-Amaldi P, Cattaneo A (1993) "Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of xenopus oocytes. " Biochem. Biophys. Res. Commun. 197(2) 422-427

73 Biocca S, Pierandrei-Amaldi P, Campioni N, Cattaneo A (1994) "Intracellular immunization with cytosolic recombinant antibodies. " Biotechnology. (N. Y). 12(4) 396-399

74 Werge TM, Baldari CT, Telford JL (1994) "Intracellular single chain Fv antibody inhibits Ras activity in T-cell antigen receptor stimulated Jurkat cells. " FEBS. Lett. 351(3) 393-396

75 Montano X, Jimenez A (1995) "Intracellular expression of the monoclonal anti-ras antibody Y13-259 blocks the transforming activity of ras oncogenes. " Cell Growth Differ. 6(5) 597-605

76 Cochet O, Kenigsberg M, Delumeau I, Virone-Oddos A, Multon MC, et al (1998) "Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression. " Cancer Res. 58(6) 1170-1176

77 Levin R, Mhashilkar AM, Dorfman T, Bukovsky A, Zani C, et al (1997) "Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. " Mol. Med. 3(2) 96-110

78 Maciejewski JP, Weichold FF, Young NS, Cara A, Zella D, et al (1995) "Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro [see comments]. " Nat. Med. 1(7) 667-673

79 Levy-Mintz P, Duan L, Zhang H, Hu B, Dornadula G, et al (1996) "Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase [published erratum appears in J Virol 1998 Apr;72(4) 3505-6]. " J. Virol. 70(12) 8821-8832

80 Mhashilkar AM, Bagley J, Chen SY, Szilvay AM, Helland DG, Marasco WA (1995) "Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. " Embo J. 14(7) 1542-1551

81 Duan L, Bagasra O, Laughlin MA, Oakes JW, Pomerantz RJ (1994) "Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. " Proc. Natl. Acad. Sci. U. S. A. 91(11) 5075-5079

82 Wu Y, Duan L, Zhu M, Hu B, Kubota S, et al (1996) "Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev variations in viral inhibition [published erratum appears in J Virol 1998 Apr;72(4) 3505-6]. " J. Virol. 70(5) 3290-3297

83 Signäs C, Katze MG, Persson H, Philipson L (1982) "An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse. " Nature 299(5879) 175-178

84 Wold WS, Cladaras C, Deutscher SL, Kapoor QS (1985) "The 19-kDa glycoprotein coded by region E3 of adenovirus. Purification, characterization, and structural analysis. " J. Biol. Chem. 260(4) 2424-2431

85 Andersson M, Pääbo S, Nilsson T, Peterson PA (1985) "Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. " Cell 43(1) 215-222

86 Burgert HG, Kvist S (1985) "An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. " Cell 41(3) 987-997

87 Pääbo S, Bhat BM, Wold WS, Peterson PA (1987) "A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum. " Cell 50(2) 311-317

88 Gabathuler R, Kvist S (1990) "The endoplasmic reticulum retention signal of the E3/19K protein of adenovirus type 2 consists of three separate amino acid segments at the carboxy terminus. " J. Cell Biol. 111(5 Pt 1) 1803-1810

89 Jackson MR, Nilsson T, Peterson PA (1990) "Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. " Embo J. 9(10) 3153-3162

90 Cosson P, Letourneur F (1994) "Coatomer interaction with di-lysine endoplasmic reticulum retention motifs. " Science 263(5153) 1629-1631

91 Jackson MR, Nilsson T, Peterson PA (1993) "Retrieval of transmembrane proteins to the endoplasmic reticulum. " J. Cell Biol. 121(2) 317-333

92 Ahmed CM, Chanda RS, Stow ND, Zain BS (1982) "The nucleotide sequence of mRNA for the Mr 19 000 glycoprotein from early gene block III of adenovirus 2. " Gene 20(3) 339-346

93 Persson H, Jansson M, Philipson L (1980) "Synthesis and genomic site for an adenovirus type 2 early glycoprotein. " J. Mol. Biol. 136(4) 375-394

94 Pääbo S, Weber F, Nilsson T, Schaffner W, Peterson PA (1986) "Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. " Embo J. 5(8) 1921-1927

95 Burgert HG, Kvist S (1987) "The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. " Embo J. 6(7) 2019-2026

96 Lehner PJ, Karttunen JT, Wilkinson GW, Cresswell P (1997) "The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. " Proc. Natl. Acad. Sci. U. S. A. 94(13) 6904-6909

97 Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL (1996) "Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. " Proc. Natl. Acad. Sci. U. S. A. 93(21) 11327-11333

98 Früh K, Gruhler A, Krishna RM, Schoenhals GJ (1999) "A comparison of viral immune escape strategies targeting the MHC class I assembly pathway. " Immunol. Rev. 168 157-166

99 Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, et al (1997) "A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. " Immunity 6(1) 57-66

100 Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Früh K (1996) "Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. " Proc. Natl. Acad. Sci. U. S. A. 93(20) 10990-10995

101 Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL (1996) "The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. " Cell 84(5) 769-779

102 Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RM, Campbell AE (1995) "Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. " J. Virol. 69(8) 4830-4841

103 Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, et al (1996) "Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction [see comments]. " Nature 384(6608) 432-438

104 York IA, Roop C, Andrews DW, Riddell SR, Graham FL, Johnson DC (1994) "A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. " Cell 77(4) 525-535

105 Hill AB, Barnett BC, McMichael AJ, McGeoch DJ (1994) "HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. " J. Immunol. 152(6) 2736-2741

106 Früh K, Ahn K, Djaballah H, Sempé P, van Endert PM, et al (1995) "A viral inhibitor of peptide transporters for antigen presentation. " Nature 375(6530) 415-418

107 Ahn K, Meyer TH, Uebel S, Sempé P, Djaballah H, et al (1996) "Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. " Embo J. 15(13) 3247-3255

108 Tomazin R, Hill AB, Jugovic P, York I, van Endert P, et al (1996) "Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. " Embo J. 15(13) 3256-3266

109 Galocha B, Hill A, Barnett BC, Dolan A, Raimondi A, et al (1997) "The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. " J. Exp. Med. 185(9) 1565-1572

110 Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, et al (1997) "The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. " Immunity 6(5) 613-621

111 Hengel H, Koopmann JO, Flohr T, Muranyi W, Goulmy E, et al (1997) "A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. " Immunity 6(5) 623-632

112 Nerem RM (1992) "Tissue engineering in the USA. " Med. Biol. Eng. Comput. 30(4) CE8-CE12

113 Eaglstein WH, Falanga V (1998) "Tissue engineering for skin an update. " J. Am. Acad. Dermatol. 39(6) 1007-1010

114 Pomahac B, Svensjö T, Yao F, Brown H, Eriksson E (1998) "Tissue engineering of skin. " Crit. Rev. Oral Biol. Med. 9(3) 333-344

115 Robert H, Bahuaud J (1999) "Autologous chondrocyte implantation. A review of techniques and preliminary results. " Rev. Rhum. Engl. Ed. 66(12) 724-727

116 Brittberg M (1999) "Autologous chondrocyte transplantation. " Clin. Orthop. Oct(367 Suppl) S147-S155

117 Häuselmann HJ, Flura T, Marti C, Hauser N, Hedbom E (1998) "Von der Chondrozytenkultur zum Gelenkknorpelersatz. Entwicklung von De-novo-Knorpel in vitro. " Schweiz. Med. Wochenschr. 128(21) 824-832

118 Riordan SM, Williams R (1999) "Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis. " J. Gastroenterol. Hepatol. 14(8) 757-770

119 Riordan S, Williams R (1997) "Bioartificial liver support developments in hepatocyte culture and bioreactor design. " Br. Med. Bull. 53(4) 730-744

120 Reach G, Darquy S, Poitout V (1998) "Use of islet cells in cell therapy. " Transfus. Clin. Biol. 5(1) 88-96

121 Dunnett SB, Kendall AL, Watts C, Torres EM (1997) "Neuronal cell transplantation for Parkinson's and Huntington's diseases. " Br. Med. Bull. 53(4) 757-776

122 Prasad KN, Clarkson ED, La Rosa FG, Edwards-Prasad J, Freed CR (1998) "Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism a review. " Mol Genet Metab 65(1) 1-9

123 Bordenave L, Rémy-Zolghadri M, Fernandez P, Bareille R, Midy D (1999) "Clinical performance of vascular grafts lined with endothelial cells. " Endothelium 6(4) 267-275

124 Auböck J, Irschick E, Romani N, Kompatscher P, Höpfl R, et al (1988) "Rejection, after a slightly prolonged survival time, of Langerhans cell-free allogeneic cultured epidermis used for wound coverage in humans. " Transplantation 45(4) 730-737

125 Rouabhia M, Germain L, Bélanger F, Auger FA (1993) "Cultured epithelium allografts Langerhans cell and Thy-1+ dendritic epidermal cell depletion effects on allograft rejection. " Transplantation 56(2) 259-264

126 Sorensen JC (1998) "Living skin equivalents and their application in wound healing. " Clin. Podiatr. Med. Surg. 15(1) 129-137

127 Phillips TJ (1998) "New skin for old developments in biological skin substitutes [editorial; comment]. " Arch. Dermatol. 134(3) 344-349

128 Kirsner RS, Falanga V, Eaglstein WH (1998) "The development of bioengineered skin. " Trends Biotechnol. 16(6) 246-249

129 Rheinwald JG, Green H (1975) " Serial cultivation of strains of human epidermal keratinocytes the formation of keratinizing colonies from single cells. " Cell 6(3) 331-343

130 Rheinwald JG, Green H (1977) "Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. " Nature 265(5593) 421-424

131 Gilchrest BA (1983) "In vitro assessment of keratinocyte aging. " J. Invest. Dermatol. 81(1 Suppl) 184s-189s

132 Odessey R (1992) "Addendum multicenter experience with cultured epidermal autograft for treatment of burns. " J. Burn Care Rehabil. 13(1) 174-180

133 Phillips TJ, Gilchrest BA (1992) "Clinical applications of cultured epithelium. " Epithelial Cell Biol. 1(1) 39-46

134 Límová M, Mauro T (1995) "Treatment of leg ulcers with cultured epithelial autografts clinical study and case reports. " Ostomy Wound Manage. 41(8) 48-50,52,54-60

135 Hefton JM, Caldwell D, Biozes DG, Balin AK, Carter DM (1986) "Grafting of skin ulcers with cultured autologous epidermal cells. " J. Am. Acad. Dermatol. 14(3) 399-405

136 Leigh IM, Purkis PE (1986) "Culture grafted leg ulcers. " Clin. Exp. Dermatol. 11(6) 650-652

137 tpi Transplant Information pte (2000) "Menschliche Haut aus Haaren gezüchtet. " http://www.tpiweb.com/aktuell/000107.htm

138 Silvers WK, Collins NH (1979) "The behavior of H-Y-incompatible neonatal skin grafts in rats. " Transplantation 28(1) 57-59

139 Viklickð V, Poláckovä M, Wabik B (1975) "Immune capacity of mice tolerating a weakly incompatible skin allograft. I. Tolerance induction by neonatal skin graft in adult recipients or by neonatal inoculation of adult cells. " Folia Biol. (Praha). 21(4) 209-218

140 Brain A, Purkis P, Coates P, Hackett M, Navsaria H, Leigh I (1989) "Survival of cultured allogeneic keratinocytes transplanted to deep dermal bed assessed with probe specific for Y chromosome. " Bmj. 298(6678) 917-919

141 Kirsner RS, Falanga V, Eaglstein WH (1993) "The biology of skin grafts. Skin grafts as pharmacologic agents [see comments]. " Arch. Dermatol. 129(4) 481-483

142 Phillips TJ (1991) "Cultured epidermal allografts--a temporary or permanent solution? " Transplantation 51(5) 937-941

143 Phillips TJ, Bhawan J, Leigh IM, Baum HJ, Gilchrest BA (1990) "Cultured epidermal autografts and allografts a study of differentiation and allograft survival. " J. Am. Acad. Dermatol. 23(2 Pt 1) 189-198

144 Phillips TJ, Kehinde O, Green H, Gilchrest BA (1989) "Treatment of skin ulcers with cultured epidermal allografts. " J. Am. Acad. Dermatol. 21(2 Pt 1) 191-199

145 De Luca M, Albanese E, Cancedda R, Viacava A, Faggioni A, et al (1992) "Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study. " Arch. Dermatol. 128(5) 633-638

146 Mol MA, Nanninga PB, van Eendenburg JP, Westerhof W, Mekkes JR, van Ginkel CJ (1991) "Grafting of venous leg ulcers. An intraindividual comparison between cultured skin equivalents and full-thickness skin punch grafts [see comments]. " J. Am. Acad. Dermatol. 24(1) 77-82

147 Teepe RG, Koebrugge EJ, Ponec M, Vermeer BJ (1990) "Fresh versus cryopreserved cultured allografts for the treatment of chronic skin ulcers. " Br. J. Dermatol. 122(1) 81-89

148 Teepe RG, Roseeuw DI, Hermans J, Koebrugge EJ, Altena T, et al (1993) "Randomized trial comparing cryopreserved cultured epidermal allografts with hydrocolloid dressings in healing chronic venous ulcers. " J. Am. Acad. Dermatol. 29(6) 982-988

149 Clark RA (1993) "Basics of cutaneous wound repair. " J. Dermatol. Surg. Oncol. 19(8) 693-706

150 Greiling D, Clark RA (1997) "Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. " J. Cell Sci. 110(Pt 7) 861-870

151 Choucair MM, Phillips TJ (1997) "What is new in clinical research in wound healing. " Dermatol. Clin. 15(1) 45-58

152 Kraut JD, Eckhardt AJ (1995) "Combined simultaneous application of cultured epithelial autografts and Alloderm. " Wounds 7 137-142

153 O'Connor NE, Gallico GG, Compton CC, Briggs S, Remensyder J (1990) "OConnor NE et al. Long term results in major pediatric burns treated with cultured epithelial autografts. " Proc. Am. Burn. Assoc. 22 174

154 Desai MH, Mlakar JM, McCauley RL, Abdullah KM, Rutan RL, et al (1991) "Lack of long-term durability of cultured keratinocyte burn-wound coverage a case report. " J. Burn Care Rehabil. 12(6) 540-545

155 Warden G (1993) "The fifth quinquennium 1989 to 1993. " J. Burn Care Rehabil. 14(2 Pt 2) 247-251

156 Burke JF, Yannas IV, Quinby WC Jr, Bondoc CC, Jung WK (1981) "Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. " Ann. Surg. 194(4) 413-428

157 Yannas IV, Burke JF (1980) "Design of an artificial skin. I. Basic design principles. " J. Biomed. Mater. Res. 14(1) 65-81

158 Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH (1980) "Design of an artificial skin. II. Control of chemical composition. " J. Biomed. Mater. Res. 14(2) 107-132

159 Contard P, Bartel TL, Jacobs L 2d, Perlish JS, MacDonald ED 2d, et al (1993) "Culturing keratinocytes and fibroblasts in a three-dimensional mesh results in epidermal differentiation and formation of a basal lamina-anchoring zone. " J. Invest. Dermatol. 100(1) 35-39

160 Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, et al (1998) "Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group [see comments]. " Arch. Dermatol. 134(3) 293-300

161 Sambrock J, Fritsch EF, Maniatis T (1989) "Molecular cloning a laboratory manual " Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press. 2nd ed.

162 Davis L, Kuehl M, Battey J (1994) "Basic Methods in Molecular Biology " Norwalk, CT, USA: Appleton & Lange. 2nd ed.

163 Chen SY, Khouri Y, Bagley J, Marasco WA (1994) "Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. " Proc. Natl. Acad. Sci. U. S. A. 91(13) 5932-5936

164 Kolls J, Peppel K, Silva M, Beutler B (1994) "Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer [published erratum appears in Proc Natl Acad Sci U S A 1994 Mar 1;91(5) 1979]. " Proc. Natl. Acad. Sci. U. S. A. 91(1) 215-219

165 Graham FL, Prevec L (1991) "Manipulation of adenovirus vector. " In Methods in Molecular Biology, ed. FL Graham, pp. 109-128. Clifton, NJ, USA: The Humana Press Inc.

166 Brown JD (1997) "A rapid, non-toxic protocol for sequence-ready plasmid DNA [Article in Technical Tips Online T01281]. " http: //tto.biomednet.com/> Posted: 26 Nov 1997.

167 Laemmli UK (1970) "Cleavage of structural proteins during the assembly of the head of bacteriophage T4. " Nature 227(259) 680-685

168 Lindl T, Bauer J (1994) "Zell- und Gewebekultur " Stuttgart: Gustav Fischer Verlag. 3rd ed.

169 Granberg C, Blomberg K, Hemmilä I, Lövgren T (1988) "Determination of cytotoxic T lymphocyte activity by time-resolved fluorometry using europium-labelled concanavalin A-stimulated cells as targets. " J. Immunol. Methods 114(1-2) 191-195

170 Volgmann T, Klein-Struckmeier A, Mohr H (1989) "A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity. " J. Immunol. Methods 119(1) 45-51

171 Maley DT, Simon P (1990) "Cytotoxicity assays using cryopreserved target cells pre-labeled with the fluorescent marker europium. " J. Immunol. Methods 134(1) 61-70

172 Bouma GJ, van der Meer-Prins PM, van Bree FP, van Rood JJ, Claas FH (1992) "Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51. " Hum. Immunol. 35(2) 85-92

173 Cui J, Bystryn JC (1992) "An improved europium release assay for complement-mediated cytolysis. " J. Immunol. Methods 147(1) 13-19

174 Blomberg K, Ulfstedt AC (1993) "Fluorescent europium chelates as target cell markers in the assessment of natural killer cell cytotoxicity. " J. Immunol. Methods 160(1) 27-34

175 Lövgren J, Blomberg K (1994) "Simultaneous measurement of NK cell cytotoxicity against two target cell lines labelled with fluorescent lanthanide chelates. " J. Immunol. Methods 173(1) 119-125

176 Bohlen H, Manzke O, Engert A, Hertel M, Hippler-Altenburg R, et al (1994) "Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation. " J. Immunol. Methods 173(1) 55-62

177 Patel AK, Boyd PN (1995) "An improved assay for antibody dependent cellular cytotoxicity based on time resolved fluorometry. " J. Immunol. Methods 184(1) 29-38

178 Blomberg K, Granberg C, Hemmilä I, Lövgren T (1986) "Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. " J. Immunol. Methods 86(2) 225-229

179 Blomberg K, Granberg C, Hemmilä I, Lövgren T (1986) "Europium-labelled target cells in an assay of natural killer cell activity. II. A novel non-radioactive method based on time-resolved fluorescence. significance and specificity of the method. " J. Immunol. Methods 92(1) 117-123

180 Soini E, Hemmilä I (1979) "Fluoroimmunoassay present status and key problems. " Clin. Chem. 25(3) 353-361

181 Soini E, Kojola H (1983) "Time-resolved fluorometer for lanthanide chelates--a new generation of nonisotopic immunoassays. " Clin. Chem. 29(1) 65-68

182 Hemmilä I, Dakubu S, Mukkala VM, Siitari H, Lövgren T (1984) "Europium as a label in time-resolved immunofluorometric assays. " Anal. Biochem. 137(2) 335-343

183 "Europium replaces 51Cr as a marker in cytotoxicity assays (1994) " In Wallac Application Notes

184 "Time-resolved fluorometry - the key to improved assay sensitivity (2000) " http://www.wallac.com/catalog/trf.htm

185 Martin AC (1997) "Antibodies - Structure and Sequence The Chothia Numbering Scheme. " http://www.biochem.ucl.ac.uk/~martin/abs/GeneralInfo.html#chothianum

186 Martin AC, Thornton JM (1996) "Structural families in loops of homologous proteins automatic classification, modelling and application to antibodies. " J. Mol. Biol. 263(5) 800-815

187 Lewis MJ, Sweet DJ, Pelham HR (1990) "The ERD2 gene determines the specificity of the luminal ER protein retention system. " Cell 61(7) 1359-1363

188 Pelham HR (1989) "Control of protein exit from the endoplasmic reticulum. " Annu. Rev. Cell Biol. 5 1-23

189 Lewis MJ, Pelham HR (1992) "Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum. " Cell 68(2) 353-364

190 Wilson DW, Lewis MJ, Pelham HR (1993) "pH-dependent binding of KDEL to its receptor in vitro. " J. Biol. Chem. 268(10) 7465-7468

191 Beier DC, Cox JH, Vining DR, Cresswell P, Engelhard VH (1994) "Association of human class I MHC alleles with the adenovirus E3/19K protein. " J. Immunol. 152(8) 3862-3872

192 López-Botet M, Bellón T (1999) "Natural killer cell activation and inhibition by receptors for MHC class I. " Curr. Opin. Immunol. 11(3) 301-307

193 Shaw S, Turni LA, Katz KS (eds.) (1999) "Protein Reviews On the Web (PROW) " http://www.ncbi.nlm.nih.gov/PROW/ Posted: 15 Okt 1999.

194 Leibson PJ (1997) "Signal transduction during natural killer cell activation inside the mind of a killer. " Immunity 6(6) 655-661

195 Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH (1998) "Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells [see comments] " Nature 391(6668) 703-707

196 Colonna M, Navarro F, Bellón T, Llano M, García P, et al (1997) "A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [see comments]. " J. Exp. Med. 186(11) 1809-1818

197 Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, et al (1998) "HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [see comments]. " Nature 391(6669) 795-799

198 Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998) "Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. " J. Exp. Med. 187(5) 813-818

199 Lee N, Llano M, Carretero M, Ishitani A, Navarro F, et al (1998) "HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A [see comments]. " Proc. Natl. Acad. Sci. U. S. A. 95(9) 5199-5204

200 Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE (1998) "HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. " J. Immunol. 160(10) 4951-4960

201 Braud VM, Allan DS, Wilson D, McMichael AJ (1998) "TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. " Curr. Biol. 8(1) 1-10

202 Carretero M, Palmieri G, Llano M, Tullio V, Santoni A, et al (1998) "Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A evidence for receptor function in heterologous transfectants. " Eur. J. Immunol. 28(4) 1280-1291

203 Cantoni C, Biassoni R, Pende D, Sivori S, Accame L, et al (1998) "The activating form of CD94 receptor complex CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. " Eur. J. Immunol. 28(1) 327-338

204 Ryan JC, Niemi EC, Nakamura MC, Seaman WE (1995) "NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. " J. Exp. Med. 181(5) 1911-1915

205 Bezouska K, Yuen CT, O'Brien J, Childs RA, Chai W, et al (1994) "Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity [published erratum appears in Nature 1996 Apr 11;380(6574) 559]. " Nature 372(6502) 150-157

206 Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, et al (1998) "Molecular cloning of NKp46 a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. " J. Exp. Med. 188(5) 953-960

207 Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, et al (1999) "Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. " J. Exp. Med. 190(10) 1505-1516

208 Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, et al (1999) "NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. " J. Exp. Med. 189(5) 787-796

209 Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, et al (1999) "NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. " Eur. J. Immunol. 29(5) 1656-1666

210 Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, et al (1998) "NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. " J. Exp. Med. 187(12) 2065-2072

211 Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D (1991) "Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. " Nature 349(6307) 329-331

212 Ljunggren HG, Van Kaer L, Ploegh HL, Tonegawa S (1994) "Altered natural killer cell repertoire in Tap-1 mutant mice. " Proc. Natl. Acad. Sci. U. S. A. 91(14) 6520-6524

213 Höglund P, Ohlén C, Carbone E, Franksson L, Ljunggren HG, et al (1991) "Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. " Proc. Natl. Acad. Sci. U. S. A. 88(22) 10332-10336

214 Shimizu Y, DeMars R (1989) "Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. " Eur. J. Immunol. 19(3) 447-451

215 Storkus WJ, Alexander J, Payne JA, Dawson JR, Cresswell P (1989) "Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. " Proc. Natl. Acad. Sci. U. S. A. 86(7) 2361-2364

216 Carosella ED, Dausset J, Kirszenbaum M (1996) "HLA-G revisited. " Immunol. Today 17(9) 407-409

217 Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R (1990) "A class I antigen, HLA-G, expressed in human trophoblasts. " Science 248(4952) 220-223

218 King A, Loke YW, Chaouat G (1997) "NK cells and reproduction [see comments]. " Immunol. Today 18(2) 64-66

219 Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, et al (1998) "HLA-G expression in melanoma a way for tumor cells to escape from immunosurveillance. " Proc. Natl. Acad. Sci. U. S. A. 95(8) 4510-4515

220 Pazmany L, Mandelboim O, Valés-Gómez M, Davis DM, Reyburn HT, Strominger JL (1996) "Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. " Science 274(5288) 792-795

221 Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, et al (1998) "p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. " Eur. J. Immunol. 28(6) 1980-1990

222 Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, et al (2000) "Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. " Science 287(5455) 1031-1033

223 Navarro F, Llano M, Bellón T, Colonna M, Geraghty DE, López-Botet M (1999) "The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. " Eur. J. Immunol. 29(1) 277-283

224 Werner KG (ed.) (1998) "Handlungsleitlinie für die ambulante Behandlung von Verbrennungen 1. und 2. Grades. " Posted: 4 Aug 1998. http://www.cnhfi.de/Verbrennung.htm

225 Stark HJ, Baur M, Breitkreutz D, Mirancea N, Fusenig NE (1999) "Organotypic keratinocyte cocultures in defined medium with regular epidermal morphogenesis and differentiation. " J. Invest. Dermatol. 112(5) 681-691

[Titelseite] [1] [2] [3] [4] [5] [Bibliographie] [Anhang] [Abkürzungsverzeichnis] [Danksagung] [Lebenslauf] [Selbständigkeitserklärung]

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiML DTD Version 2.0
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Thu Nov 23 16:57:30 2000